Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BIOCRYST PHARMACEUTICALS INC | Exec. Director, Finance - PAO | Common Stock | 16.7K | $101K | $6.05 | Dec 19, 2022 | Direct |
BIOCRYST PHARMACEUTICALS INC | Exec. Director, Finance - PAO | Emp. Stock Option (Right to Buy) | 8.5K | Dec 19, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BCRX | BIOCRYST PHARMACEUTICALS INC | Dec 19, 2022 | 2 | $0 | 4 | Dec 21, 2022 | Exec. Director, Finance - PAO |
BCRX | BIOCRYST PHARMACEUTICALS INC | Dec 15, 2022 | 1 | -$4.85K | 4 | Dec 19, 2022 | Exec. Director, Finance - PAO |
BCRX | BIOCRYST PHARMACEUTICALS INC | Dec 1, 2022 | 3 | -$99.7K | 4 | Dec 2, 2022 | Exec. Director, Finance - PAO |
BCRX | BIOCRYST PHARMACEUTICALS INC | Mar 1, 2022 | 3 | -$28.7K | 4 | Mar 3, 2022 | Exec. Director, Finance - PAO |
BCRX | BIOCRYST PHARMACEUTICALS INC | Dec 14, 2021 | 2 | $0 | 4 | Dec 16, 2021 | Exec. Director, Finance - PAO |